|
|
Minerva BiOTECH Corporation is an innovative Canadian
Biotechnology Company that is committed to the development,
commercialization and worldwide marketing of cost-effective
diagnostic test kits for the initial screening of various
serious infectious diseases and other health related conditions.
|
“
Rapid, accurate and early
diagnosis of infection is the
cornerstone of worldwide disease prevention and treatment.
It is clear that even in the developed world not enough people
are getting tested, or are waiting too long to be tested. ” |
Minerva
BiOTECH has developed the VScan™ line of rapid test kits for rapid, initial point-of-care screening for:
HIV 1 & 2, Hepatitis B and C, Tuberculosis,
West Nile virus and Dengue Fever.
Recently the diagnostic division has been expanded to now
offer test kits for sexual transmitted diseases (STDs) and for
the initial detection of cancer. The STD kit tests for
Syphilis and the Cancer kit tests for Prostate Cancer.
Other innovative kits are under development.
|
Meets or Exceeds Existing Testing Standards
|
VScan™ test kits have been thoroughly tested and evaluated in the lab, on volunteers (under Doctor supervision) and by independent sources (including Governments) and have been shown to meet or exceed the existing global standards for both
sensitivity and specificity.
The VScan™
Rapid HIV Test Kit is approved for sale in:
China, Hong Kong, India, Taiwan, Nigeria, The Congo and Peru.
Regulatory approvals are ongoing in some 20+ other countries.
The kits are not for sale in Canada or other countries where regulatory
approval has not been received.
|
A Medical
Services International Inc. Company
P.O. Box 21137 - Terwillegar PO
Edmonton, Alberta Canada T6R 2V4 |
|
Immediate Results (under 15 minutes)